Forest Laboratories, Inc.
(NYSE: FRX) announced that study results show Lexapro (escitalopram
oxalate) significantly improved symptoms of depression as compared to
placebo treatment and was well tolerated in adolescents, aged 12-17, with
major depressive disorder (MDD), according to phase III data presented at
the 2008 Annual Meeting of the American (more…)

Now that spring is officially upon us, it is that time of year when we all start to think about spritzing up our homes for the start of the new season but if you are one of the 5.2 million people in the UK who suffer from asthma, this is especially important.
Dust, dirt and allergens tend to collect over the winter months causing a potentially dangerous build up of asthma triggers in your home. 90% of people with asthma tell us that dust triggers their condition and in the (more…)

In honor of the 11th
annual Food Allergy Awareness Week, May 11-17, The Food Allergy &
Anaphylaxis Network (FAAN) unveiled its new advocacy initiative "Five Steps
Forward for Food Allergy" at an educational briefing on Capitol Hill.
This initiative addresses the challenges of food (more…)

Men’s Health News
A new Cancer Research UK clinical trial has been launched to investigate the best treatment options for men who have had surgery for early stage prostate cancer.
The trial - named RADICALS - is partly funded by the Medical Research Council (MRC) and Cancer Research UK and aims to provide the definitive guide on when and how to use radiotherapy (more…)

St. Jude Medical, Inc. (Generic zithromax pills no prescription NYSE:STJ) announced pilot study results from the first multi-center study investigating deep brain stimulation (DBS) of Brodmann Area 25 for major depressive disorder.
Results of the study, which were presented at the American Psychiatric Association (APA) meeting in Washington, D.C., found that 6 months after the procedure, (more…)